Concetta Rafaniello - Publications

Hepatic Safety Profile of Atomoxetine and Methylphenidate in Patients with ADHD: Disproportionality Analysis Using EudraVigilance Database Data.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 07, 2026

The onset of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with the use of decongestant agents: a European pharmacovigilance analysis.

Journal: Pharmacological reports : PR

Published: April 17, 2026

Uncovering prognostic biomarkers through a pharmacovigilance study: the case of RDW.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 13, 2025

Hypogammaglobulinemia in patients with multiple sclerosis receiving disease modifying therapies: disproportionality analysis using the EudraVigilance database.

Journal: Expert opinion on drug safety

Published: April 16, 2025

Real-world safety comparison of liraglutide and semaglutide in weight management: Insights from European pharmacovigilance data.

Journal: European journal of pharmacology

Published: April 14, 2025

A systematic review and pharmacovigilance analysis of the risk of agranulocytosis associated with metamizole use.

Journal: Scientific reports

Published: March 31, 2025

Effects of SGLT2i therapy on cardiac electrophysiological properties and arrhythmias in diabetic patients with implantable cardiac defibrillator.

Journal: Pharmacological research

Published: March 04, 2025

miRNA Signatures in Alveolar Macrophages Related to Cigarette Smoke: Assessment and Bioinformatics Analysis.

Journal: International journal of molecular sciences

Published: December 20, 2024

Pharmacovigilance study on the reporting frequency of atrial fibrillation with immune checkpoint inhibitors: insights from FDA Adverse Event Reporting System.

Journal: Therapeutic advances in drug safety

Published: June 12, 2024

Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 20, 2024

Two Years of Active Pharmacovigilance Surveillance and Therapeutic Reconciliation in Frail Populations: The MEAP 3.0 Study.

Journal: Journal of clinical medicine

Published: October 30, 2023

Drug Utilization and Measurement of Medication Adherence: A Real World Study of Psoriasis in Italy.

Journal: Pharmaceutics

Published: October 20, 2023